.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Remedi is stocked at 274 licensed dispensaries across Illinois, Pennsylvania, and 3 other states, 144 of them in Illinois, with the deepest coverage in Chicago, East Peoria, Naperville, Normal, and Arlington Heights. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In July 2026, Remedi concentrated heavily in Concentrates at 88.19% share with year-over-year growth of 51.17% and month-over-month expansion of 41.45%, while Tincture & Sublingual held 9.22% share with a -2.28% YoY shift and a -13.02% MoM dip. Capsules contributed 2.59% share with a -39.63% YoY change but a 35.28% MoM lift, and the brand-wide average price declined 7.13% YoY alongside total brand sales up 38.77% YoY. In Illinois Concentrates, Remedi stood at rank 17, indicating depth in a single category even as Capsules shows tactical month-on-month recovery; this mix implies July 2026 gains leaned on a high-growth, high-share core while secondary categories contracted or rebounded unevenly.
The mix tilt toward Concentrates (88.19% share and rank 17 in Illinois) coupled with a 7.13% YoY price decline suggests a volume-led strategy where price elasticity favored uptake, evidenced by 41.45% MoM growth in the lead category and 38.77% YoY brand sales growth. At the same time, Tincture & Sublingual’s -13.02% MoM and -2.28% YoY shifts, contrasted with Capsules’ 35.28% MoM uptick despite a -39.63% YoY drag, indicate positioning that prioritizes depth over breadth; the pattern implies Remedi’s competitive posture hinges on defending and climbing category rank in Concentrates while using targeted pricing and SKU focus to selectively stabilize smaller formats rather than expanding the portfolio footprint broadly.
Competitive Landscape
Remedi sits at rank #17 in Illinois Concentrates in July 2026, improving 4 positions from #21 year over year and rising 3 positions from #20 in April 2026 to reach its peak at #17 in July 2026; meanwhile, category leaders such as Aeriz held #1 both year over year and in July 2026 while growing sales 35.0%, and IC Collective advanced from #8 to #3 alongside a 93.1% sales increase. Compared with RYTHM holding #2 across the same periods and Cresco Labs shifting from #7 to #5 with 10.8% sales growth, Remedi’s upward move is narrower in rank change yet consistent across both the 12-month (+4) and 3-month (+3) windows; the pattern implies Remedi is edging into mid-tier relevance, but without a step-change catalyst it risks being outpaced by faster-rising competitors.
Notable Products
Goblin Punch RSO (1g) posted the largest movement in July 2026 with a 455.9% month-over-month jump, climbing into rank 4 and signaling breakout traction off a smaller base. Indica Relief RSO Syringe (0.5g) also surged 65.8% MoM to rank 1, while CBD/THC 1:5 Rest Tincture (20mg CBD, 100mg THC, 30ml) fell 27.0% MoM to rank 7, indicating a split in demand between high-THC RSO and traditional tinctures. Five of the top eight are Concentrates ranked 1 through 5 and 8, concentrating share at the top while Tincture & Sublingual products sit at ranks 6 and 7 with mixed MoM outcomes; this pattern implies Remedi’s product momentum is pivoting toward RSO-led Concentrates and away from tincture reliance.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
